Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs GoodRx

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and GoodRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 129 · Grade C

GoodRx

Visit GoodRx Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 72 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make GoodRx a bad call — it's best for readers comparing online follow-up with filling an existing prescription through a pharmacy. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
77
Transparency
90
68
Access Breadth
93
86
Clinical Oversight
92
68
Track Record
88
84
CoreAge RxBrief Score 94 · 72GoodRx

Price, coverage & the tracker

CoreAge RxGoodRx
Brief Score94/100 (A)72/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Separate care fee of $39 per 30 days on Care Direct. Wegovy pen $199 for two eligible introductory fills, then $349. Tablet prices vary by strength.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Separate care fee of $39 per 30 days on Care Direct. Zepbound KwikPen advertised from $299; confirm the price for your prescribed strength.

CoverageUS only; restrictions by state, confirmed at intakeGoodRx says Care Direct weight-loss visits are unavailable in Alabama and Louisiana. Pharmacy access varies.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

GoodRx: GoodRx Care Direct advertises $39 for clinical care. Medication is charged separately and introductory offers have restrictions.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.